Equities

Medinet Co Ltd

2370:TYO

Medinet Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)45.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.00m
  • 1 Year change-10.00%
  • Beta2.2180
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments4,3964,4994,096
Total Receivables, Net217171219
Total Inventory675042
Prepaid expenses402626
Other current assets, total486221
Total current assets4,7694,8074,405
Property, plant & equipment, net478537620
Goodwill, net------
Intangibles, net11310247
Long term investments212485166
Note receivable - long term560563569
Other long term assets(498)(417)(430)
Total assets5,6346,0785,378
LIABILITIES
Accounts payable554641
Accrued expenses716559
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.531.993.39
Other current liabilities, total219166172
Total current liabilities347279275
Total long term debt0.782.314.30
Total debt2.314.307.69
Deferred income tax6512841
Minority interest------
Other liabilities, total177156155
Total liabilities590566475
SHAREHOLDERS EQUITY
Common stock5,7375,8925,082
Additional paid-in capital5781,361551
Retained earnings (accumulated deficit)(1418)(2094)(822)
Treasury stock - common0.000.00--
Unrealized gain (loss)14735392
Other equity, total0--0.00
Total equity5,0445,5124,903
Total liabilities & shareholders' equity5,6346,0785,378
Total common shares outstanding232212179
Treasury shares - common primary issue0.000.000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.